Skip to Content
Merck
CN

Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology.

Clinical chemistry (1992-12-01)
K Hyland, P T Clayton
ABSTRACT

Aromatic L-amino acid decarboxylase (EC. 4.1.1.28) deficiency is a newly described inborn error of metabolism that affects serotonin and dopamine biosynthesis. The major biochemical markers for this disease are increases of L-dopa, 3-methoxytyrosine, and 5-hydroxytryptophan in urine, plasma, and cerebrospinal fluid together with decreased cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid. In addition, concentrations of vanillactic acid are increased in the urine. Specific HPLC and gas chromatography-mass spectrometry methods are described that permit the identification and measurement of these metabolites in the above body fluids. Simplified assays for human plasma L-dopa decarboxylase and liver L-dopa and 5-hydroxytryptophan decarboxylase, used to demonstrate the enzyme deficiency, are also reported.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Homovanillic acid, Fluorimetric reagent
Supelco
Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
N-Acetyl-L-tyrosine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
3,4-Dihydroxy-L-phenylalanine, ≥98% (TLC)
Sigma-Aldrich
3,4-Dihydroxy-L-phenylalanine, Vetec, reagent grade, 98%